Low Back Pain Lbp clinical trials

Explore recruiting low back pain lbp clinical trials.

Recruiting low back pain lbp studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Low Back Pain Lbp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2, multicenter, randomized, double blind, active controlled, parallel group study assessing the analgesic effect and safety of two doses of DFL24412 in patients with chronic low back pain compared to Ketoprofen Lysine Salt (KLS)

Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A double blind, double dummy, multicenter, randomized, placebo- and active-controlled clinical trial to evaluate effectiveness of Tricortin 1000 in patients affected by chronic low back pain

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo- and Active-Controlled Phase III Therapeutic Superiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Diclofenac + Orphenadrine + Paracetamol to Diclofenac (Cataflam®) and Orphenadrine + Paracetamol (Norgesic®) in Patients with Acute Severe Low Back Pain.

Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo and Active-Controlled Phase III Therapeutic Superiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Diclofenac potassium + Thiocolchicoside to Diclofenac potassium (Cataflam®) in Patients with Acute Severe Low Back Pain.

Cyprus, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Multicentre, Double-blind, two Parallel Group, Clinical Phase III Trial for Comparing the Efficacy and Tolerability of a combination IM product of Diclofenac and Thiocolchicoside vs. Diclofenac (Voltaren®) IM in patients with acute moderate to severe low back pain

Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, double-blind, parallel-groups, active - and placebo-controlled study to Evaluate the efficacy of a fixed combination of diclofenac 75 mg + thiocolchicoside 4 mg as solution for injection, in reLIEving back pain symptoms. Controlled study vs. dicloFenac 75 mg solution for injection and placebo. RELIEF Study

Italy, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

Low Back Pain Lbp trials by city

Low Back Pain Lbp in Toronto Low Back Pain Lbp in Vancouver Low Back Pain Lbp in Montreal Low Back Pain Lbp in Calgary Low Back Pain Lbp in Edmonton Low Back Pain Lbp in Ottawa Low Back Pain Lbp in Winnipeg Low Back Pain Lbp in Quebec City Low Back Pain Lbp in Hamilton Low Back Pain Lbp in Kitchener Low Back Pain Lbp in London Low Back Pain Lbp in Halifax Low Back Pain Lbp in New York Low Back Pain Lbp in Los Angeles Low Back Pain Lbp in Chicago Low Back Pain Lbp in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease